المؤلفون: Rouhard, Stéphanie, Buysschaert, Martin, Alexopoulou, Orsalia, Preumont, Vanessa

المساهمون: UCL - SSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutrition, UCL - (SLuc) Service d'endocrinologie et de nutrition

المصدر: Diabetes & metabolic syndrome, Vol. 14, no.2, p. 65-69 (2021)

مصطلحات موضوعية: Adult, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Glucose, Humans, Hypoglycemia, Male, Middle Aged, Monitoring, Ambulatory, Patient Satisfaction, Prospective Studies, Quality of Life, Flash glucose monitoring, Freestyle libre, HbA1c, Satisfaction, Type 1 diabetes

العلاقة: boreal:250785; http://hdl.handle.net/2078Test.1/250785; info:pmid/31991294; urn:ISSN:1871-4021; urn:EISSN:1878-0334

الإتاحة: https://doi.org/10.1016/j.dsx.2019.12.007Test
http://hdl.handle.net/2078Test.1/250785

المؤلفون: Grimmelmann I., Momma M., Zimmer L., Hassel J. C., Heinzerling L., Pfohler C., Loquai C., Ruini C., Utikal J., Thoms K. -M., Kahler K. C., Eigentler T., Herbst R. A., Meier F., Debus D., Berking C., Kochanek C., Ugurel S., Gutzmer R.

المساهمون: Grimmelmann, I., Momma, M., Zimmer, L., Hassel, J. C., Heinzerling, L., Pfohler, C., Loquai, C., Ruini, C., Utikal, J., Thoms, K. -M., Kahler, K. C., Eigentler, T., Herbst, R. A., Meier, F., Debus, D., Berking, C., Kochanek, C., Ugurel, S., Gutzmer, R.

مصطلحات موضوعية: diabete, diabetes mellitu, immune checkpoint inhibitor, immune-related adverse event, ipilimumab, lipase, nivolumab, pancreatiti, pd-1 inhibitor, pembrolizumab, adult, aged, 80 and over, biomarker, blood glucose, type 1, exocrine pancreatic insufficiency, female, germany, human, male, melanoma, middle aged, predictive value of test, retrospective studie, skin neoplasm, time factor, treatment outcome, up-regulation, young adult

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33812141; info:eu-repo/semantics/altIdentifier/wos/WOS:000647678000001; volume:149; firstpage:1; lastpage:10; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11573/1682141Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105295200

الإتاحة: https://doi.org/10.1016/j.ejca.2021.02.017Test
https://hdl.handle.net/11573/1682141Test

المؤلفون: Vincent van der Noort, Jacobus A. Burgers, Harry J.M. Groen, Jos A. Stigt, Idris Bahce, Egbert F. Smit, B. E. van den Borne, Bonne Biesma, Joachim G.J.V. Aerts, Gerarda J.M. Herder, Anne-Marie C. Dingemans, Andrew D. Vincent

المساهمون: Pulmonary Medicine, Neurosurgery, MUMC+: MA Med Staf Spec Longziekten (9), Pulmonologie, RS: N.P.I Privaatrecht niet geprog, Promovendi ODB, Family Medicine, RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Pulmonary medicine, CCA - Innovative therapy

المصدر: Dingemans, A M C, Groen, H J M, Herder, G J M, Stigt, J A, Smit, E F, Bahce, I, Burgers, J A, van den Borne, B E E M, Biesma, B, Vincent, A, van der Noort, V & Aerts, JG 2015, ' A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)(aEuro) ', Annals of Oncology, vol. 26, no. 11, pp. 2286-2293 . https://doi.org/10.1093/annonc/mdv370Test
Annals of Oncology, 26(11), 2286-2293. Elsevier Ltd.
Annals of Oncology, 26(11), 2286-2293. Oxford University Press

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Paclitaxel, Urology, VINORELBINE, Phases of clinical research, bevacizumab, Vinorelbine, DONOR, THERAPY, Carboplatin, chemistry.chemical_compound, CISPLATIN, SDG 3 - Good Health and Well-being, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Lung cancer, Aged, Neoplasm Staging, Cisplatin, Aged, 80 and over, NITRIC-OXIDE, business.industry, Hazard ratio, Area under the curve, nonsmall-cell lung cancer, Hematology, Middle Aged, medicine.disease, VEGF, nitroglycerin, Oncology, chemistry, Anesthesia, Female, Hypoxia-Inducible Factor 1, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce79aa82e47a39fa2e0aaa7862cfa29Test
https://doi.org/10.1093/annonc/mdv370Test

المؤلفون: Thomas, A. L., Cox, G., Sharma, R. A., Steward, W. P., Shields, F., Jeyapalan, K., Muller, S., O'Byrne, Kenneth J.

المصدر: European Journal of Cancer

مصطلحات موضوعية: Gemcitabine, Non-small cell lung cancer, Paclitaxel, Pneumonitis, prednisolone, adult, aged, antineoplastic activity, article, cancer staging, cancer survival, clinical article, clinical trial, dose response, drug efficacy, female, human, lung non small cell cancer, male, phase 1 clinical trial, phase 2 clinical trial, pneumonia, priority journal, treatment outcome, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Cohort Studies, Deoxycytidine, Dose-Response Relationship

العلاقة: Thomas, A. L., Cox, G., Sharma, R. A., Steward, W. P., Shields, F., Jeyapalan, K., Muller, S., & O'Byrne, Kenneth J. (2000) Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer : report of a phase I/II dose-escalating study. European Journal of Cancer, 36(18), pp. 2329-2334.; https://eprints.qut.edu.au/65775Test/; Faculty of Health; Institute of Health and Biomedical Innovation

الإتاحة: https://doi.org/10.1016/S0959-8049Test(00)00341-5
https://eprints.qut.edu.au/65775Test/